This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,143.85, is for the delivery of 100 tablets of 8 mg hydromorphone hydrochloride extended-release. It is a firm fixed-price delivery order contract with an ultimate completion date of January 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,282.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydromorphone 2 mg/ml, a pain management medication, with a performance period through April 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FCD32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The $4,207.56 firm fixed-price delivery order is for the supply of 16mg hydromorphone hydrochloride extended-release tablets. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,475.20, is a Firm Fixed Price Delivery Order for the supply of HYDROMORPHONE 500 MG/50 ML VL 50ML. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.05, is a Firm Fixed Price Delivery Order for the supply of HYDROMORPHONE 1 MG/ML CARPUJCTML, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.20 firm fixed-price delivery order is for HYDROMORPHONE 500 MG/50 ML VL 50ML, a pharmaceutical product. The contract has a completion date of February 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $2,754.60 firm fixed price delivery order is for the supply of Hydromorphone 1 mg/ml, a prescription medication, to support military treatment programs and facilities. The award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,597.00 Firm Fixed Price Delivery Order is for the supply of Hydromorphone 2 mg/ml vials. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,383.29, is for the delivery of Hydromorphone HCL ER 8 mg tablets in quantities of 100s. The contract is a firm-fixed price delivery order, with a completion date of June 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $3,397.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Hydromorphone 1 mg/ml vials, a pain management medication. The contract has a completion date of September 14, 2022 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...